Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Coronavirus | Brief Report

Identification of the protein coding capability of coronavirus defective viral genomes by mass spectrometry

Authors: Ching-Hung Lin, Feng-Cheng Hsieh, Chien-Chen Lai, Wei-Chen Wang, Cheng-Yu Kuo, Chun-Chun Yang, Hsuan-Wei Hsu, Hon-Man-Herman Tam, Cheng-Yao Yang, Hung-Yi Wu

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

During coronavirus infection, in addition to the well-known coronavirus genomes and subgenomic mRNAs, an abundance of defective viral genomes (DVGs) can also be synthesized. In this study, we aimed to examine whether DVGs can encode proteins in infected cells. Nanopore direct RNA sequencing and liquid chromatography-tandem mass spectrometry (LC–MS/MS) analysis were employed. With the protein databases generated by nanopore direct RNA sequencing and the cell lysates derived from the RNA–protein pull-down assay, six DVG-encoded proteins were identified by LC–MS/MS based on the featured fusion peptides caused by recombination during DVG synthesis. The results suggest that the coronavirus DVGs have the capability to encode proteins. Consequently, future studies determining the biological function of DVG-encoded proteins may contribute to the understanding of their roles in coronavirus pathogenesis and the development of antiviral strategies.
Literature
1.
go back to reference Brian DA, Baric RS. Coronavirus genome structure and replication. Curr Top Microbiol Immunol. 2005;287:1–30.PubMed Brian DA, Baric RS. Coronavirus genome structure and replication. Curr Top Microbiol Immunol. 2005;287:1–30.PubMed
2.
go back to reference Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006;117(1):17–37.CrossRefPubMed Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006;117(1):17–37.CrossRefPubMed
3.
go back to reference Xiao SY, Wu YJ, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring. J Med Virol. 2020;92(5):464–7.CrossRefPubMedPubMedCentral Xiao SY, Wu YJ, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring. J Med Virol. 2020;92(5):464–7.CrossRefPubMedPubMedCentral
4.
go back to reference Yang WJ, Cao QQ, Qin L, Wang XY, Cheng ZH, Pan AS, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388–93.CrossRefPubMedPubMedCentral Yang WJ, Cao QQ, Qin L, Wang XY, Cheng ZH, Pan AS, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388–93.CrossRefPubMedPubMedCentral
5.
go back to reference Sawicki SG, Sawicki DL. Coronavirus transcription: a perspective. Curr Top Microbiol Immunol. 2005;287:31–55.PubMed Sawicki SG, Sawicki DL. Coronavirus transcription: a perspective. Curr Top Microbiol Immunol. 2005;287:31–55.PubMed
7.
go back to reference Girgis S, Xu ZK, Oikonomopoulos S, Fedorova AD, Tchesnokov EP, Gordon CJ et al. Evolution of naturally arising SARS-CoV-2 defective interfering particles. Commun Biol. 2022;5(1). Girgis S, Xu ZK, Oikonomopoulos S, Fedorova AD, Tchesnokov EP, Gordon CJ et al. Evolution of naturally arising SARS-CoV-2 defective interfering particles. Commun Biol. 2022;5(1).
8.
go back to reference Nomburg J, Meyerson M, DeCaprio JA. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2. Genome Med. 2020;12(1). Nomburg J, Meyerson M, DeCaprio JA. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2. Genome Med. 2020;12(1).
9.
go back to reference Lin CH, Chen B, Chao DY, Hsieh FC, Lai CC, Wang WC, et al. Biological characterization of coronavirus noncanonical transcripts in vitro and in vivo. Virol J. 2023;20(1):232.CrossRefPubMedPubMedCentral Lin CH, Chen B, Chao DY, Hsieh FC, Lai CC, Wang WC, et al. Biological characterization of coronavirus noncanonical transcripts in vitro and in vivo. Virol J. 2023;20(1):232.CrossRefPubMedPubMedCentral
10.
go back to reference Viehweger A, Krautwurst S, Lamkiewicz K, Madhugiri R, Ziebuhr J, Holzer M, et al. Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis. Genome Res. 2019;29(9):1545–54.CrossRefPubMedPubMedCentral Viehweger A, Krautwurst S, Lamkiewicz K, Madhugiri R, Ziebuhr J, Holzer M, et al. Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis. Genome Res. 2019;29(9):1545–54.CrossRefPubMedPubMedCentral
12.
go back to reference Dalton K, Casais R, Shaw K, Stirrups K, Evans S, Britton P, et al. cis-acting sequences required for coronavirus infectious bronchitis virus defective-RNA replication and packaging. J Virol. 2001;75(1):125–33.CrossRefPubMedPubMedCentral Dalton K, Casais R, Shaw K, Stirrups K, Evans S, Britton P, et al. cis-acting sequences required for coronavirus infectious bronchitis virus defective-RNA replication and packaging. J Virol. 2001;75(1):125–33.CrossRefPubMedPubMedCentral
13.
go back to reference Penzes Z, Tibbles KW, Shaw K, Britton P, Brown TD, Cavanagh D. Generation of a defective RNA of avian coronavirus infectious bronchitis virus (IBV). Defective RNA of coronavirus IBV. Adv Exp Med Biol. 1995;380:563–9.CrossRefPubMed Penzes Z, Tibbles KW, Shaw K, Britton P, Brown TD, Cavanagh D. Generation of a defective RNA of avian coronavirus infectious bronchitis virus (IBV). Defective RNA of coronavirus IBV. Adv Exp Med Biol. 1995;380:563–9.CrossRefPubMed
14.
go back to reference Wu M, Zhou E, Sheng R, Fu X, Li J, Jiang C et al. Defective interfering particles of influenza virus and their characteristics, impacts, and use in vaccines and antiviral strategies: a systematic review. Viruses. 2022;14(12). Wu M, Zhou E, Sheng R, Fu X, Li J, Jiang C et al. Defective interfering particles of influenza virus and their characteristics, impacts, and use in vaccines and antiviral strategies: a systematic review. Viruses. 2022;14(12).
16.
go back to reference Vasilijevic J, Zamarreno N, Oliveros JC, Rodriguez-Frandsen A, Gomez G, Rodriguez G et al. Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients. PLoS Pathog. 2017;13(10). Vasilijevic J, Zamarreno N, Oliveros JC, Rodriguez-Frandsen A, Gomez G, Rodriguez G et al. Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients. PLoS Pathog. 2017;13(10).
17.
go back to reference Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, et al. Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence. Nat Commun. 2017;8(1):799.CrossRefPubMedPubMedCentral Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, et al. Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence. Nat Commun. 2017;8(1):799.CrossRefPubMedPubMedCentral
18.
go back to reference Calain P, Monroe MC, Nichol ST. Ebola virus defective interfering particles and persistent infection. Virology. 1999;262(1):114–28.CrossRefPubMed Calain P, Monroe MC, Nichol ST. Ebola virus defective interfering particles and persistent infection. Virology. 1999;262(1):114–28.CrossRefPubMed
19.
go back to reference Genoyer E, Lopez CB. The impact of defective viruses on infection and immunity. Ann Rev Virol, 2019;6:547–66. Genoyer E, Lopez CB. The impact of defective viruses on infection and immunity. Ann Rev Virol, 2019;6:547–66.
20.
go back to reference Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science. 2006;311(5758):236–8.CrossRefPubMed Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science. 2006;311(5758):236–8.CrossRefPubMed
21.
go back to reference Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W et al. A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol. 2009;83(16):8021-31. Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W et al. A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol. 2009;83(16):8021-31.
22.
go back to reference Boergeling Y, Rozhdestvensky TS, Schmolke M, Resa-Infante P, Robeck T, Randau G, et al. Evidence for a novel mechanism of influenza virus-induced type I interferon expression by a defective RNA-encoded protein. PLoS Pathog. 2015;11(5):e1004924.CrossRefPubMedPubMedCentral Boergeling Y, Rozhdestvensky TS, Schmolke M, Resa-Infante P, Robeck T, Randau G, et al. Evidence for a novel mechanism of influenza virus-induced type I interferon expression by a defective RNA-encoded protein. PLoS Pathog. 2015;11(5):e1004924.CrossRefPubMedPubMedCentral
23.
go back to reference Zhou T, Gilliam NJ, Li S, Spandau S, Osborn RM, Connor S, et al. Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection. mBio. 2023;14(3):e0025023.CrossRefPubMed Zhou T, Gilliam NJ, Li S, Spandau S, Osborn RM, Connor S, et al. Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection. mBio. 2023;14(3):e0025023.CrossRefPubMed
24.
go back to reference Chaturvedi S, Vasen G, Pablo M, Chen X, Beutler N, Kumar A, et al. Identification of a therapeutic interfering particle-a single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance. Cell. 2021;184(25):6022–36e18.CrossRefPubMedPubMedCentral Chaturvedi S, Vasen G, Pablo M, Chen X, Beutler N, Kumar A, et al. Identification of a therapeutic interfering particle-a single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance. Cell. 2021;184(25):6022–36e18.CrossRefPubMedPubMedCentral
25.
go back to reference Zhao H, Zhang C, Lam H, Meng X, Peng Z, Yeung ML, et al. Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza a virus in vivo. Signal Transduct Target Ther. 2022;7(1):266.CrossRefPubMedPubMedCentral Zhao H, Zhang C, Lam H, Meng X, Peng Z, Yeung ML, et al. Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza a virus in vivo. Signal Transduct Target Ther. 2022;7(1):266.CrossRefPubMedPubMedCentral
26.
go back to reference Lin CH, Chen B, Chao DY, Hsieh FC, Yang CC, Hsu HW, et al. Unveiling the biology of defective viral genomes in vitro and in vivo: implications for gene expression and pathogenesis of coronavirus. Virol J. 2023;20(1):225.CrossRefPubMedPubMedCentral Lin CH, Chen B, Chao DY, Hsieh FC, Yang CC, Hsu HW, et al. Unveiling the biology of defective viral genomes in vitro and in vivo: implications for gene expression and pathogenesis of coronavirus. Virol J. 2023;20(1):225.CrossRefPubMedPubMedCentral
27.
go back to reference Panda AC, Martindale JL, Gorospe M. Affinity pulldown of biotinylated RNA for detection of protein-RNA complexes. Bio Protoc. 2016;6(24). Panda AC, Martindale JL, Gorospe M. Affinity pulldown of biotinylated RNA for detection of protein-RNA complexes. Bio Protoc. 2016;6(24).
29.
go back to reference Chien HJ, Chu YW, Chen CW, Juang YM, Chien MW, Liu CW, et al. 2-DE combined with two-layer feature selection accurately establishes the origin of oolong tea. Food Chem. 2016;211:392–9.CrossRefPubMed Chien HJ, Chu YW, Chen CW, Juang YM, Chien MW, Liu CW, et al. 2-DE combined with two-layer feature selection accurately establishes the origin of oolong tea. Food Chem. 2016;211:392–9.CrossRefPubMed
30.
go back to reference Tastet C, Lescuyer P, Diemer H, Luche S, van Dorsselaer A, Rabilloud T. A versatile electrophoresis system for the analysis of high- and low-molecular-weight proteins. Electrophoresis. 2003;24(11):1787–94.CrossRefPubMedPubMedCentral Tastet C, Lescuyer P, Diemer H, Luche S, van Dorsselaer A, Rabilloud T. A versatile electrophoresis system for the analysis of high- and low-molecular-weight proteins. Electrophoresis. 2003;24(11):1787–94.CrossRefPubMedPubMedCentral
31.
go back to reference Chang RY, Hofmann MA, Sethna PB, Brian DA. A cis-acting function for the coronavirus leader in defective interfering RNA replication. J Virol. 1994;68(12):8223–31.CrossRefPubMedPubMedCentral Chang RY, Hofmann MA, Sethna PB, Brian DA. A cis-acting function for the coronavirus leader in defective interfering RNA replication. J Virol. 1994;68(12):8223–31.CrossRefPubMedPubMedCentral
32.
go back to reference Mu J, Fang Y, Yang Q, Shu T, Wang A, Huang M, et al. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2. Cell Discov. 2020;6:65.CrossRefPubMedPubMedCentral Mu J, Fang Y, Yang Q, Shu T, Wang A, Huang M, et al. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2. Cell Discov. 2020;6:65.CrossRefPubMedPubMedCentral
34.
35.
go back to reference Zuniga S, Cruz JLG, Sola I, Mateos-Gomez PA, Palacio L, Enjuanes L. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J Virol. 2010;84(4):2169–75.CrossRefPubMed Zuniga S, Cruz JLG, Sola I, Mateos-Gomez PA, Palacio L, Enjuanes L. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J Virol. 2010;84(4):2169–75.CrossRefPubMed
Metadata
Title
Identification of the protein coding capability of coronavirus defective viral genomes by mass spectrometry
Authors
Ching-Hung Lin
Feng-Cheng Hsieh
Chien-Chen Lai
Wei-Chen Wang
Cheng-Yu Kuo
Chun-Chun Yang
Hsuan-Wei Hsu
Hon-Man-Herman Tam
Cheng-Yao Yang
Hung-Yi Wu
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Coronavirus
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02252-3

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.